Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover why budgeting mistakes happen and how to prevent them. This intro provides strategies to reduce errors and enhance your plan.
18,943 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
With $850,000 saved at 59, a couple can expect about $2,600-$2,800 a month in early retirement from portfolios, befor...
XRP outperformed broader markets as on-chain activity surged, even as ETF-linked products faced notable outflows. The...
Enphase Energy and SolarEdge surged roughly 8% in morning trading as investors chase AI data-center power plays, exte...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
U.S. Bancorp is emerging as a premier retirement safe haven thanks to a steady dividend, solid capital position and e...
One AI stock sits at the intersection of great product momentum and misunderstood AI economics. This piece explains w...
Public headlines about daveigh chase’s cause death show how quickly medical bills and end-of-life costs can add up. L...
Rivian has faced a choppy 2026 after huge 2025 gains. This piece explains why april could turning point for Rivian in...
Two fintech giants sit at the center of modern investing. This guide breaks down Coinbase Global and Robinhood Market...
Tempo, a Layer 1 blockchain backed by Stripe, has officially launched its mainnet with a sharp focus on AI agent paym...
Australian regulators have activated full Travel Rule checks for crypto transfers. Exchanges and other service provid...